Wendy Chamberlain
“Rigorous evidence, honest language, and the patient’s perspective — these are not competing values. They are the only standard worth holding.”
Clinical Voice. Patient-Centered Writing.
Dr. Wendy Chamberlain is a board-certified physician in Internal Medicine with subspecialty training in Infectious Disease, and one of North America’s most respected voices in evidence-based health communications. As Editor-in-Chief of Sunny Pharma®, she holds final editorial authority over all content published on sunnypharma.info — setting and enforcing the standards that ensure every article, drug guide, and patient resource reflects the most current, credible clinical science available.
Dr. Chamberlain received her Doctor of Medicine from the University of Toronto Faculty of Medicine, completed her internal medicine residency and infectious disease fellowship at University Health Network, and holds a Master of Public Health from the Harvard T.H. Chan School of Public Health. She is a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) and holds a Certificate in Medical Journalism from Columbia University Graduate School of Journalism.
Over a career spanning more than two decades, Dr. Chamberlain has practiced clinical medicine at St. Michael’s Hospital in Toronto, contributed to international HIV treatment programs in sub-Saharan Africa through the WHO’s HIV/AIDS Department, and built a parallel career as a medical writer and editor whose work has appeared in the New England Journal of Medicine, JAMA Internal Medicine, The BMJ, and The Lancet Infectious Diseases.
She joined Sunny Pharma® as Editor-in-Chief because she believes that patients who cannot afford branded medications — particularly those living with HIV or Hepatitis C — deserve the same quality of health information as those who receive care at major academic medical centers.
Rigorous evidence, honest language, and the patient’s perspective — these are not competing values. They are the only standard worth holding.
Published Work & Journal Contributions
A selection of published and contributed works across peer-reviewed journals and clinical education platforms.
-
Integrase Inhibitor Resistance in Treatment-Experienced HIV Patients: A Clinician’s Framework for Second-Line Decision-Making
-
HIV Treatment Literacy and Medication Adherence: A Systematic Review of Patient Education Interventions in High-Income Countries
-
Plain Language Summaries of HIV Guidelines: An Urgent Need for Standardization in Patient-Facing Clinical Communication
-
Long-Acting Injectable ART in Resource-Limited Settings: Opportunities, Barriers, and Communication Considerations
-
Communicating Undetectable = Untransmittable (U=U) in Primary Care: A Guide for Non-Specialist Physicians
-
Health Literacy and ART Adherence: A Multi-Centre Cohort Study Across Toronto, Vancouver, and Montreal
-
Bictegravir-Based Single-Tablet Regimens: 96-Week Clinical Outcomes and Patient Quality-of-Life Data
-
Hepatitis C Elimination by 2030: The Role of Simplified Direct-Acting Antiviral Regimens in Canada’s National Strategy
-
Affordable Antiretrovirals and the Right to Health: A Physician’s Ethical Case for Generic HIV Medications
Editorial Standards & Conflict of Interest
Dr. Chamberlain does not hold equity or advisory relationships with any antiretroviral or antiviral pharmaceutical manufacturer. Her compensation is a fixed editorial stipend, fully independent of commercial outcomes for Sunny Pharma®. She discloses this in accordance with ICMJE guidelines. All clinical claims are cross-referenced against current FDA prescribing information, DHHS guidelines, AASLD/IDSA HCV Guidance, and primary peer-reviewed literature before any content is approved for publication.
Credentials independently verified: November 2025 · University of Toronto Faculty of Medicine Physician Registry · RCPSC Fellowship Verification